Sight Sciences, Inc.
SGHTNasdaqCIK 1531177HealthcareFiscal year ends Dec 31
Reports and events: 101 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1012:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-341346 |
| 2026-08-0520:21 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-335204 |
| 2026-08-0520:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-335092 |
| 2026-06-0520:06 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-259546 |
| 2026-05-0620:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-209116 |
| 2026-05-0620:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-208959 |
| 2026-04-2312:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-171887 |
| 2026-04-2220:36 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001140361-26-016138 |
| 2026-03-3011:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-130386 |
| 2026-03-0421:19 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-091558 |
| 2026-03-0421:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-091482 |
| 2026-02-0322:30 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-26-035915 |
| 2026-01-1312:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-011106 |
| 2025-11-0621:19 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269613 |
| 2025-11-0621:11 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-269525 |
| 2025-10-1711:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-241948 |
| 2025-09-3020:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-225041 |
| 2025-08-2720:05 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001531177-25-000007 |
| 2025-08-0720:19 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105065 |
| 2025-08-0720:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-105012 |
| 2025-06-0520:46 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-25-135930 |
| 2025-05-0820:16 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-067008 |
| 2025-05-0820:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-066935 |
| 2025-04-2321:08 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0001140361-25-015218 |
| 2025-04-2220:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-056724 |
| 2025-03-1323:24 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-039015 |
| 2025-03-0721:08 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-035500 |
| 2025-03-0521:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-033556 |
| 2025-01-2821:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-009820 |
| 2025-01-1413:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-005104 |
| 2024-12-1121:36 ET | 8-K | 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0000950170-24-135402 |
| 2024-11-0721:24 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123403 |
| 2024-11-0721:11 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-123336 |
| 2024-10-0313:31 ET | 8-K | 8.01 Other events | 0000950170-24-112038 |
| 2024-09-2620:48 ET | 8-K | 8.01 Other events | 0000950170-24-109665 |
| 2024-08-0220:27 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-090008 |
| 2024-08-0120:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-089277 |
| 2024-06-0722:46 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-070062 |
| 2024-05-3013:19 ET | 8-K | 8.01 Other events | 0000950170-24-066276 |
| 2024-05-0620:16 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-053572 |
| 2024-05-0220:07 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-052094 |
| 2024-04-2912:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-120159 |
| 2024-04-2610:00 ET | DEF 14A | Proxy statementPeriod 2024-06-06 | 0001140361-24-022158 |
| 2024-03-1323:32 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-030278 |
| 2024-03-0721:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-027971 |
| 2024-02-0221:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-022830 |
| 2024-01-2321:07 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-012979 |
| 2023-12-1822:13 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-23-297713 |
| 2023-12-0721:51 ET | 8-K | 8.01 Other events | 0001193125-23-290749 |
| 2023-12-0121:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-287443 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.